Baird Maintains Outperform on Cardinal Health, Raises Price Target to $137
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Eric Coldwell maintains an Outperform rating on Cardinal Health (NYSE:CAH) and raises the price target from $130 to $137.
August 15, 2024 | 10:59 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Baird analyst Eric Coldwell maintains an Outperform rating on Cardinal Health and raises the price target from $130 to $137.
The raised price target and maintained Outperform rating from a reputable analyst are positive signals for investors, likely leading to a short-term increase in CAH's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100